Sector Gamma As Bluebird Bio, Inc. Transaction History

Sector Gamma As

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $1.32 Million - $2.23 Million	-48,490 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $363,885 - $883,285	-13,910 Reduced 22.29%	48,490 $2.23 Million
Q4 2019 Feb 12, 2020	BUY	$46.96 - $61.67 $2.93 Million - $3.85 Million	62,400 New	62,400 $5.48 Million
Q3 2018 Nov 08, 2018	SELL	$88.86 - $117.49 $1.51 Million - $2 Million	-17,000 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$99.64 - $127.59 $1.69 Million - $2.17 Million	17,000 New	17,000 $2.67 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.